Penicillamine Market, Global Outlook and Forecast 2022-2028
Penicillamine, sold under the trade names of Cuprimine, is a medication primarily used for the treatment of Wilson's disease. It is also used for people with kidney stones who have high urine cystine levels, rheumatoid arthritis, and various heavy metal poisonings. It is taken by mouth.
This report contains market size and forecasts of Penicillamine in global, including the following market information:
Global Penicillamine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Penicillamine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Penicillamine companies in 2021 (%)
The global Penicillamine market was valued at 85 million in 2021 and is projected to reach US$ 93 million by 2028, at a CAGR of 1.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Penicillamine include Bausch Health, Mylan, Novartis, Teva, Merck Sharp and Dohme, Taisho Seiyaku, Fresenius, Mitchells and Butlers and Biochem Chemopharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Penicillamine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Penicillamine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Penicillamine Market Segment Percentages, by Type, 2021 (%)
Global Penicillamine Market Segment Percentages, by Application, 2021 (%)
Global Penicillamine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Penicillamine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Penicillamine revenues share in global market, 2021 (%)
Key companies Penicillamine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Penicillamine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Penicillamine in global, including the following market information:
Global Penicillamine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Penicillamine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Penicillamine companies in 2021 (%)
The global Penicillamine market was valued at 85 million in 2021 and is projected to reach US$ 93 million by 2028, at a CAGR of 1.2% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablet Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Penicillamine include Bausch Health, Mylan, Novartis, Teva, Merck Sharp and Dohme, Taisho Seiyaku, Fresenius, Mitchells and Butlers and Biochem Chemopharma, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Penicillamine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Penicillamine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Penicillamine Market Segment Percentages, by Type, 2021 (%)
- Tablet
- Capsule
Global Penicillamine Market Segment Percentages, by Application, 2021 (%)
- Lead Poisoning
- Wilson's Disease
- Cystine Renal Calculi
- Refractory Rheumatoid Arthritis
- Severe Rheumatoid Arthritis
Global Penicillamine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Penicillamine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Penicillamine revenues share in global market, 2021 (%)
Key companies Penicillamine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Penicillamine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Bausch Health
- Mylan
- Novartis
- Teva
- Merck Sharp and Dohme
- Taisho Seiyaku
- Fresenius
- Mitchells and Butlers
- Biochem Chemopharma
- Kendrick Labs
- Panacea Pharma
- UCB Pharma
- IFET
- DCC Plc
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Penicillamine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Penicillamine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PENICILLAMINE OVERALL MARKET SIZE
2.1 Global Penicillamine Market Size: 2021 VS 2028
2.2 Global Penicillamine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Penicillamine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Penicillamine Players in Global Market
3.2 Top Global Penicillamine Companies Ranked by Revenue
3.3 Global Penicillamine Revenue by Companies
3.4 Global Penicillamine Sales by Companies
3.5 Global Penicillamine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Penicillamine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Penicillamine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Penicillamine Players in Global Market
3.8.1 List of Global Tier 1 Penicillamine Companies
3.8.2 List of Global Tier 2 and Tier 3 Penicillamine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Penicillamine Market Size Markets, 2021 & 2028
4.1.2 Tablet
4.1.3 Capsule
4.2 By Type - Global Penicillamine Revenue & Forecasts
4.2.1 By Type - Global Penicillamine Revenue, 2017-2022
4.2.2 By Type - Global Penicillamine Revenue, 2023-2028
4.2.3 By Type - Global Penicillamine Revenue Market Share, 2017-2028
4.3 By Type - Global Penicillamine Sales & Forecasts
4.3.1 By Type - Global Penicillamine Sales, 2017-2022
4.3.2 By Type - Global Penicillamine Sales, 2023-2028
4.3.3 By Type - Global Penicillamine Sales Market Share, 2017-2028
4.4 By Type - Global Penicillamine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Penicillamine Market Size, 2021 & 2028
5.1.2 Lead Poisoning
5.1.3 Wilson's Disease
5.1.4 Cystine Renal Calculi
5.1.5 Refractory Rheumatoid Arthritis
5.1.6 Severe Rheumatoid Arthritis
5.2 By Application - Global Penicillamine Revenue & Forecasts
5.2.1 By Application - Global Penicillamine Revenue, 2017-2022
5.2.2 By Application - Global Penicillamine Revenue, 2023-2028
5.2.3 By Application - Global Penicillamine Revenue Market Share, 2017-2028
5.3 By Application - Global Penicillamine Sales & Forecasts
5.3.1 By Application - Global Penicillamine Sales, 2017-2022
5.3.2 By Application - Global Penicillamine Sales, 2023-2028
5.3.3 By Application - Global Penicillamine Sales Market Share, 2017-2028
5.4 By Application - Global Penicillamine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Penicillamine Market Size, 2021 & 2028
6.2 By Region - Global Penicillamine Revenue & Forecasts
6.2.1 By Region - Global Penicillamine Revenue, 2017-2022
6.2.2 By Region - Global Penicillamine Revenue, 2023-2028
6.2.3 By Region - Global Penicillamine Revenue Market Share, 2017-2028
6.3 By Region - Global Penicillamine Sales & Forecasts
6.3.1 By Region - Global Penicillamine Sales, 2017-2022
6.3.2 By Region - Global Penicillamine Sales, 2023-2028
6.3.3 By Region - Global Penicillamine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Penicillamine Revenue, 2017-2028
6.4.2 By Country - North America Penicillamine Sales, 2017-2028
6.4.3 US Penicillamine Market Size, 2017-2028
6.4.4 Canada Penicillamine Market Size, 2017-2028
6.4.5 Mexico Penicillamine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Penicillamine Revenue, 2017-2028
6.5.2 By Country - Europe Penicillamine Sales, 2017-2028
6.5.3 Germany Penicillamine Market Size, 2017-2028
6.5.4 France Penicillamine Market Size, 2017-2028
6.5.5 U.K. Penicillamine Market Size, 2017-2028
6.5.6 Italy Penicillamine Market Size, 2017-2028
6.5.7 Russia Penicillamine Market Size, 2017-2028
6.5.8 Nordic Countries Penicillamine Market Size, 2017-2028
6.5.9 Benelux Penicillamine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Penicillamine Revenue, 2017-2028
6.6.2 By Region - Asia Penicillamine Sales, 2017-2028
6.6.3 China Penicillamine Market Size, 2017-2028
6.6.4 Japan Penicillamine Market Size, 2017-2028
6.6.5 South Korea Penicillamine Market Size, 2017-2028
6.6.6 Southeast Asia Penicillamine Market Size, 2017-2028
6.6.7 India Penicillamine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Penicillamine Revenue, 2017-2028
6.7.2 By Country - South America Penicillamine Sales, 2017-2028
6.7.3 Brazil Penicillamine Market Size, 2017-2028
6.7.4 Argentina Penicillamine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Penicillamine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Penicillamine Sales, 2017-2028
6.8.3 Turkey Penicillamine Market Size, 2017-2028
6.8.4 Israel Penicillamine Market Size, 2017-2028
6.8.5 Saudi Arabia Penicillamine Market Size, 2017-2028
6.8.6 UAE Penicillamine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bausch Health
7.1.1 Bausch Health Corporate Summary
7.1.2 Bausch Health Business Overview
7.1.3 Bausch Health Penicillamine Major Product Offerings
7.1.4 Bausch Health Penicillamine Sales and Revenue in Global (2017-2022)
7.1.5 Bausch Health Key News
7.2 Mylan
7.2.1 Mylan Corporate Summary
7.2.2 Mylan Business Overview
7.2.3 Mylan Penicillamine Major Product Offerings
7.2.4 Mylan Penicillamine Sales and Revenue in Global (2017-2022)
7.2.5 Mylan Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Penicillamine Major Product Offerings
7.3.4 Novartis Penicillamine Sales and Revenue in Global (2017-2022)
7.3.5 Novartis Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Penicillamine Major Product Offerings
7.4.4 Teva Penicillamine Sales and Revenue in Global (2017-2022)
7.4.5 Teva Key News
7.5 Merck Sharp and Dohme
7.5.1 Merck Sharp and Dohme Corporate Summary
7.5.2 Merck Sharp and Dohme Business Overview
7.5.3 Merck Sharp and Dohme Penicillamine Major Product Offerings
7.5.4 Merck Sharp and Dohme Penicillamine Sales and Revenue in Global (2017-2022)
7.5.5 Merck Sharp and Dohme Key News
7.6 Taisho Seiyaku
7.6.1 Taisho Seiyaku Corporate Summary
7.6.2 Taisho Seiyaku Business Overview
7.6.3 Taisho Seiyaku Penicillamine Major Product Offerings
7.6.4 Taisho Seiyaku Penicillamine Sales and Revenue in Global (2017-2022)
7.6.5 Taisho Seiyaku Key News
7.7 Fresenius
7.7.1 Fresenius Corporate Summary
7.7.2 Fresenius Business Overview
7.7.3 Fresenius Penicillamine Major Product Offerings
7.7.4 Fresenius Penicillamine Sales and Revenue in Global (2017-2022)
7.7.5 Fresenius Key News
7.8 Mitchells and Butlers
7.8.1 Mitchells and Butlers Corporate Summary
7.8.2 Mitchells and Butlers Business Overview
7.8.3 Mitchells and Butlers Penicillamine Major Product Offerings
7.8.4 Mitchells and Butlers Penicillamine Sales and Revenue in Global (2017-2022)
7.8.5 Mitchells and Butlers Key News
7.9 Biochem Chemopharma
7.9.1 Biochem Chemopharma Corporate Summary
7.9.2 Biochem Chemopharma Business Overview
7.9.3 Biochem Chemopharma Penicillamine Major Product Offerings
7.9.4 Biochem Chemopharma Penicillamine Sales and Revenue in Global (2017-2022)
7.9.5 Biochem Chemopharma Key News
7.10 Kendrick Labs
7.10.1 Kendrick Labs Corporate Summary
7.10.2 Kendrick Labs Business Overview
7.10.3 Kendrick Labs Penicillamine Major Product Offerings
7.10.4 Kendrick Labs Penicillamine Sales and Revenue in Global (2017-2022)
7.10.5 Kendrick Labs Key News
7.11 Panacea Pharma
7.11.1 Panacea Pharma Corporate Summary
7.11.2 Panacea Pharma Penicillamine Business Overview
7.11.3 Panacea Pharma Penicillamine Major Product Offerings
7.11.4 Panacea Pharma Penicillamine Sales and Revenue in Global (2017-2022)
7.11.5 Panacea Pharma Key News
7.12 UCB Pharma
7.12.1 UCB Pharma Corporate Summary
7.12.2 UCB Pharma Penicillamine Business Overview
7.12.3 UCB Pharma Penicillamine Major Product Offerings
7.12.4 UCB Pharma Penicillamine Sales and Revenue in Global (2017-2022)
7.12.5 UCB Pharma Key News
7.13 IFET
7.13.1 IFET Corporate Summary
7.13.2 IFET Penicillamine Business Overview
7.13.3 IFET Penicillamine Major Product Offerings
7.13.4 IFET Penicillamine Sales and Revenue in Global (2017-2022)
7.13.5 IFET Key News
7.14 DCC Plc
7.14.1 DCC Plc Corporate Summary
7.14.2 DCC Plc Business Overview
7.14.3 DCC Plc Penicillamine Major Product Offerings
7.14.4 DCC Plc Penicillamine Sales and Revenue in Global (2017-2022)
7.14.5 DCC Plc Key News
8 GLOBAL PENICILLAMINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Penicillamine Production Capacity, 2017-2028
8.2 Penicillamine Production Capacity of Key Manufacturers in Global Market
8.3 Global Penicillamine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PENICILLAMINE SUPPLY CHAIN ANALYSIS
10.1 Penicillamine Industry Value Chain
10.2 Penicillamine Upstream Market
10.3 Penicillamine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Penicillamine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 Penicillamine Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Penicillamine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PENICILLAMINE OVERALL MARKET SIZE
2.1 Global Penicillamine Market Size: 2021 VS 2028
2.2 Global Penicillamine Revenue, Prospects & Forecasts: 2017-2028
2.3 Global Penicillamine Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top Penicillamine Players in Global Market
3.2 Top Global Penicillamine Companies Ranked by Revenue
3.3 Global Penicillamine Revenue by Companies
3.4 Global Penicillamine Sales by Companies
3.5 Global Penicillamine Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 Penicillamine Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers Penicillamine Product Type
3.8 Tier 1, Tier 2 and Tier 3 Penicillamine Players in Global Market
3.8.1 List of Global Tier 1 Penicillamine Companies
3.8.2 List of Global Tier 2 and Tier 3 Penicillamine Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global Penicillamine Market Size Markets, 2021 & 2028
4.1.2 Tablet
4.1.3 Capsule
4.2 By Type - Global Penicillamine Revenue & Forecasts
4.2.1 By Type - Global Penicillamine Revenue, 2017-2022
4.2.2 By Type - Global Penicillamine Revenue, 2023-2028
4.2.3 By Type - Global Penicillamine Revenue Market Share, 2017-2028
4.3 By Type - Global Penicillamine Sales & Forecasts
4.3.1 By Type - Global Penicillamine Sales, 2017-2022
4.3.2 By Type - Global Penicillamine Sales, 2023-2028
4.3.3 By Type - Global Penicillamine Sales Market Share, 2017-2028
4.4 By Type - Global Penicillamine Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Penicillamine Market Size, 2021 & 2028
5.1.2 Lead Poisoning
5.1.3 Wilson's Disease
5.1.4 Cystine Renal Calculi
5.1.5 Refractory Rheumatoid Arthritis
5.1.6 Severe Rheumatoid Arthritis
5.2 By Application - Global Penicillamine Revenue & Forecasts
5.2.1 By Application - Global Penicillamine Revenue, 2017-2022
5.2.2 By Application - Global Penicillamine Revenue, 2023-2028
5.2.3 By Application - Global Penicillamine Revenue Market Share, 2017-2028
5.3 By Application - Global Penicillamine Sales & Forecasts
5.3.1 By Application - Global Penicillamine Sales, 2017-2022
5.3.2 By Application - Global Penicillamine Sales, 2023-2028
5.3.3 By Application - Global Penicillamine Sales Market Share, 2017-2028
5.4 By Application - Global Penicillamine Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Penicillamine Market Size, 2021 & 2028
6.2 By Region - Global Penicillamine Revenue & Forecasts
6.2.1 By Region - Global Penicillamine Revenue, 2017-2022
6.2.2 By Region - Global Penicillamine Revenue, 2023-2028
6.2.3 By Region - Global Penicillamine Revenue Market Share, 2017-2028
6.3 By Region - Global Penicillamine Sales & Forecasts
6.3.1 By Region - Global Penicillamine Sales, 2017-2022
6.3.2 By Region - Global Penicillamine Sales, 2023-2028
6.3.3 By Region - Global Penicillamine Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America Penicillamine Revenue, 2017-2028
6.4.2 By Country - North America Penicillamine Sales, 2017-2028
6.4.3 US Penicillamine Market Size, 2017-2028
6.4.4 Canada Penicillamine Market Size, 2017-2028
6.4.5 Mexico Penicillamine Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe Penicillamine Revenue, 2017-2028
6.5.2 By Country - Europe Penicillamine Sales, 2017-2028
6.5.3 Germany Penicillamine Market Size, 2017-2028
6.5.4 France Penicillamine Market Size, 2017-2028
6.5.5 U.K. Penicillamine Market Size, 2017-2028
6.5.6 Italy Penicillamine Market Size, 2017-2028
6.5.7 Russia Penicillamine Market Size, 2017-2028
6.5.8 Nordic Countries Penicillamine Market Size, 2017-2028
6.5.9 Benelux Penicillamine Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia Penicillamine Revenue, 2017-2028
6.6.2 By Region - Asia Penicillamine Sales, 2017-2028
6.6.3 China Penicillamine Market Size, 2017-2028
6.6.4 Japan Penicillamine Market Size, 2017-2028
6.6.5 South Korea Penicillamine Market Size, 2017-2028
6.6.6 Southeast Asia Penicillamine Market Size, 2017-2028
6.6.7 India Penicillamine Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America Penicillamine Revenue, 2017-2028
6.7.2 By Country - South America Penicillamine Sales, 2017-2028
6.7.3 Brazil Penicillamine Market Size, 2017-2028
6.7.4 Argentina Penicillamine Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa Penicillamine Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa Penicillamine Sales, 2017-2028
6.8.3 Turkey Penicillamine Market Size, 2017-2028
6.8.4 Israel Penicillamine Market Size, 2017-2028
6.8.5 Saudi Arabia Penicillamine Market Size, 2017-2028
6.8.6 UAE Penicillamine Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Bausch Health
7.1.1 Bausch Health Corporate Summary
7.1.2 Bausch Health Business Overview
7.1.3 Bausch Health Penicillamine Major Product Offerings
7.1.4 Bausch Health Penicillamine Sales and Revenue in Global (2017-2022)
7.1.5 Bausch Health Key News
7.2 Mylan
7.2.1 Mylan Corporate Summary
7.2.2 Mylan Business Overview
7.2.3 Mylan Penicillamine Major Product Offerings
7.2.4 Mylan Penicillamine Sales and Revenue in Global (2017-2022)
7.2.5 Mylan Key News
7.3 Novartis
7.3.1 Novartis Corporate Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Penicillamine Major Product Offerings
7.3.4 Novartis Penicillamine Sales and Revenue in Global (2017-2022)
7.3.5 Novartis Key News
7.4 Teva
7.4.1 Teva Corporate Summary
7.4.2 Teva Business Overview
7.4.3 Teva Penicillamine Major Product Offerings
7.4.4 Teva Penicillamine Sales and Revenue in Global (2017-2022)
7.4.5 Teva Key News
7.5 Merck Sharp and Dohme
7.5.1 Merck Sharp and Dohme Corporate Summary
7.5.2 Merck Sharp and Dohme Business Overview
7.5.3 Merck Sharp and Dohme Penicillamine Major Product Offerings
7.5.4 Merck Sharp and Dohme Penicillamine Sales and Revenue in Global (2017-2022)
7.5.5 Merck Sharp and Dohme Key News
7.6 Taisho Seiyaku
7.6.1 Taisho Seiyaku Corporate Summary
7.6.2 Taisho Seiyaku Business Overview
7.6.3 Taisho Seiyaku Penicillamine Major Product Offerings
7.6.4 Taisho Seiyaku Penicillamine Sales and Revenue in Global (2017-2022)
7.6.5 Taisho Seiyaku Key News
7.7 Fresenius
7.7.1 Fresenius Corporate Summary
7.7.2 Fresenius Business Overview
7.7.3 Fresenius Penicillamine Major Product Offerings
7.7.4 Fresenius Penicillamine Sales and Revenue in Global (2017-2022)
7.7.5 Fresenius Key News
7.8 Mitchells and Butlers
7.8.1 Mitchells and Butlers Corporate Summary
7.8.2 Mitchells and Butlers Business Overview
7.8.3 Mitchells and Butlers Penicillamine Major Product Offerings
7.8.4 Mitchells and Butlers Penicillamine Sales and Revenue in Global (2017-2022)
7.8.5 Mitchells and Butlers Key News
7.9 Biochem Chemopharma
7.9.1 Biochem Chemopharma Corporate Summary
7.9.2 Biochem Chemopharma Business Overview
7.9.3 Biochem Chemopharma Penicillamine Major Product Offerings
7.9.4 Biochem Chemopharma Penicillamine Sales and Revenue in Global (2017-2022)
7.9.5 Biochem Chemopharma Key News
7.10 Kendrick Labs
7.10.1 Kendrick Labs Corporate Summary
7.10.2 Kendrick Labs Business Overview
7.10.3 Kendrick Labs Penicillamine Major Product Offerings
7.10.4 Kendrick Labs Penicillamine Sales and Revenue in Global (2017-2022)
7.10.5 Kendrick Labs Key News
7.11 Panacea Pharma
7.11.1 Panacea Pharma Corporate Summary
7.11.2 Panacea Pharma Penicillamine Business Overview
7.11.3 Panacea Pharma Penicillamine Major Product Offerings
7.11.4 Panacea Pharma Penicillamine Sales and Revenue in Global (2017-2022)
7.11.5 Panacea Pharma Key News
7.12 UCB Pharma
7.12.1 UCB Pharma Corporate Summary
7.12.2 UCB Pharma Penicillamine Business Overview
7.12.3 UCB Pharma Penicillamine Major Product Offerings
7.12.4 UCB Pharma Penicillamine Sales and Revenue in Global (2017-2022)
7.12.5 UCB Pharma Key News
7.13 IFET
7.13.1 IFET Corporate Summary
7.13.2 IFET Penicillamine Business Overview
7.13.3 IFET Penicillamine Major Product Offerings
7.13.4 IFET Penicillamine Sales and Revenue in Global (2017-2022)
7.13.5 IFET Key News
7.14 DCC Plc
7.14.1 DCC Plc Corporate Summary
7.14.2 DCC Plc Business Overview
7.14.3 DCC Plc Penicillamine Major Product Offerings
7.14.4 DCC Plc Penicillamine Sales and Revenue in Global (2017-2022)
7.14.5 DCC Plc Key News
8 GLOBAL PENICILLAMINE PRODUCTION CAPACITY, ANALYSIS
8.1 Global Penicillamine Production Capacity, 2017-2028
8.2 Penicillamine Production Capacity of Key Manufacturers in Global Market
8.3 Global Penicillamine Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PENICILLAMINE SUPPLY CHAIN ANALYSIS
10.1 Penicillamine Industry Value Chain
10.2 Penicillamine Upstream Market
10.3 Penicillamine Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Penicillamine Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of Penicillamine in Global Market
Table 2. Top Penicillamine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Penicillamine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Penicillamine Revenue Share by Companies, 2017-2022
Table 5. Global Penicillamine Sales by Companies, (K Units), 2017-2022
Table 6. Global Penicillamine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Penicillamine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Penicillamine Product Type
Table 9. List of Global Tier 1 Penicillamine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Penicillamine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Penicillamine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Penicillamine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Penicillamine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Penicillamine Sales (K Units), 2017-2022
Table 15. By Type - Global Penicillamine Sales (K Units), 2023-2028
Table 16. By Application – Global Penicillamine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Penicillamine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Penicillamine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Penicillamine Sales (K Units), 2017-2022
Table 20. By Application - Global Penicillamine Sales (K Units), 2023-2028
Table 21. By Region – Global Penicillamine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Penicillamine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Penicillamine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Penicillamine Sales (K Units), 2017-2022
Table 25. By Region - Global Penicillamine Sales (K Units), 2023-2028
Table 26. By Country - North America Penicillamine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Penicillamine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Penicillamine Sales, (K Units), 2017-2022
Table 29. By Country - North America Penicillamine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Penicillamine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Penicillamine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Penicillamine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Penicillamine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Penicillamine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Penicillamine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Penicillamine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Penicillamine Sales, (K Units), 2023-2028
Table 38. By Country - South America Penicillamine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Penicillamine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Penicillamine Sales, (K Units), 2017-2022
Table 41. By Country - South America Penicillamine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Penicillamine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Penicillamine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Penicillamine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Penicillamine Sales, (K Units), 2023-2028
Table 46. Bausch Health Corporate Summary
Table 47. Bausch Health Penicillamine Product Offerings
Table 48. Bausch Health Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Mylan Corporate Summary
Table 50. Mylan Penicillamine Product Offerings
Table 51. Mylan Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Novartis Corporate Summary
Table 53. Novartis Penicillamine Product Offerings
Table 54. Novartis Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Teva Corporate Summary
Table 56. Teva Penicillamine Product Offerings
Table 57. Teva Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Merck Sharp and Dohme Corporate Summary
Table 59. Merck Sharp and Dohme Penicillamine Product Offerings
Table 60. Merck Sharp and Dohme Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Taisho Seiyaku Corporate Summary
Table 62. Taisho Seiyaku Penicillamine Product Offerings
Table 63. Taisho Seiyaku Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Fresenius Corporate Summary
Table 65. Fresenius Penicillamine Product Offerings
Table 66. Fresenius Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Mitchells and Butlers Corporate Summary
Table 68. Mitchells and Butlers Penicillamine Product Offerings
Table 69. Mitchells and Butlers Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Biochem Chemopharma Corporate Summary
Table 71. Biochem Chemopharma Penicillamine Product Offerings
Table 72. Biochem Chemopharma Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Kendrick Labs Corporate Summary
Table 74. Kendrick Labs Penicillamine Product Offerings
Table 75. Kendrick Labs Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Panacea Pharma Corporate Summary
Table 77. Panacea Pharma Penicillamine Product Offerings
Table 78. Panacea Pharma Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. UCB Pharma Corporate Summary
Table 80. UCB Pharma Penicillamine Product Offerings
Table 81. UCB Pharma Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. IFET Corporate Summary
Table 83. IFET Penicillamine Product Offerings
Table 84. IFET Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. DCC Plc Corporate Summary
Table 86. DCC Plc Penicillamine Product Offerings
Table 87. DCC Plc Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Penicillamine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 89. Global Penicillamine Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Penicillamine Production by Region, 2017-2022 (K Units)
Table 91. Global Penicillamine Production by Region, 2023-2028 (K Units)
Table 92. Penicillamine Market Opportunities & Trends in Global Market
Table 93. Penicillamine Market Drivers in Global Market
Table 94. Penicillamine Market Restraints in Global Market
Table 95. Penicillamine Raw Materials
Table 96. Penicillamine Raw Materials Suppliers in Global Market
Table 97. Typical Penicillamine Downstream
Table 98. Penicillamine Downstream Clients in Global Market
Table 99. Penicillamine Distributors and Sales Agents in Global Market
Table 1. Key Players of Penicillamine in Global Market
Table 2. Top Penicillamine Players in Global Market, Ranking by Revenue (2021)
Table 3. Global Penicillamine Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global Penicillamine Revenue Share by Companies, 2017-2022
Table 5. Global Penicillamine Sales by Companies, (K Units), 2017-2022
Table 6. Global Penicillamine Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers Penicillamine Price (2017-2022) & (US$/Unit)
Table 8. Global Manufacturers Penicillamine Product Type
Table 9. List of Global Tier 1 Penicillamine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Penicillamine Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Penicillamine Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global Penicillamine Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global Penicillamine Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global Penicillamine Sales (K Units), 2017-2022
Table 15. By Type - Global Penicillamine Sales (K Units), 2023-2028
Table 16. By Application – Global Penicillamine Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global Penicillamine Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global Penicillamine Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global Penicillamine Sales (K Units), 2017-2022
Table 20. By Application - Global Penicillamine Sales (K Units), 2023-2028
Table 21. By Region – Global Penicillamine Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global Penicillamine Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global Penicillamine Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global Penicillamine Sales (K Units), 2017-2022
Table 25. By Region - Global Penicillamine Sales (K Units), 2023-2028
Table 26. By Country - North America Penicillamine Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America Penicillamine Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America Penicillamine Sales, (K Units), 2017-2022
Table 29. By Country - North America Penicillamine Sales, (K Units), 2023-2028
Table 30. By Country - Europe Penicillamine Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe Penicillamine Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe Penicillamine Sales, (K Units), 2017-2022
Table 33. By Country - Europe Penicillamine Sales, (K Units), 2023-2028
Table 34. By Region - Asia Penicillamine Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia Penicillamine Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia Penicillamine Sales, (K Units), 2017-2022
Table 37. By Region - Asia Penicillamine Sales, (K Units), 2023-2028
Table 38. By Country - South America Penicillamine Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America Penicillamine Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America Penicillamine Sales, (K Units), 2017-2022
Table 41. By Country - South America Penicillamine Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa Penicillamine Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa Penicillamine Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa Penicillamine Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa Penicillamine Sales, (K Units), 2023-2028
Table 46. Bausch Health Corporate Summary
Table 47. Bausch Health Penicillamine Product Offerings
Table 48. Bausch Health Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 49. Mylan Corporate Summary
Table 50. Mylan Penicillamine Product Offerings
Table 51. Mylan Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 52. Novartis Corporate Summary
Table 53. Novartis Penicillamine Product Offerings
Table 54. Novartis Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 55. Teva Corporate Summary
Table 56. Teva Penicillamine Product Offerings
Table 57. Teva Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 58. Merck Sharp and Dohme Corporate Summary
Table 59. Merck Sharp and Dohme Penicillamine Product Offerings
Table 60. Merck Sharp and Dohme Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 61. Taisho Seiyaku Corporate Summary
Table 62. Taisho Seiyaku Penicillamine Product Offerings
Table 63. Taisho Seiyaku Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 64. Fresenius Corporate Summary
Table 65. Fresenius Penicillamine Product Offerings
Table 66. Fresenius Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 67. Mitchells and Butlers Corporate Summary
Table 68. Mitchells and Butlers Penicillamine Product Offerings
Table 69. Mitchells and Butlers Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 70. Biochem Chemopharma Corporate Summary
Table 71. Biochem Chemopharma Penicillamine Product Offerings
Table 72. Biochem Chemopharma Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 73. Kendrick Labs Corporate Summary
Table 74. Kendrick Labs Penicillamine Product Offerings
Table 75. Kendrick Labs Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 76. Panacea Pharma Corporate Summary
Table 77. Panacea Pharma Penicillamine Product Offerings
Table 78. Panacea Pharma Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 79. UCB Pharma Corporate Summary
Table 80. UCB Pharma Penicillamine Product Offerings
Table 81. UCB Pharma Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 82. IFET Corporate Summary
Table 83. IFET Penicillamine Product Offerings
Table 84. IFET Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 85. DCC Plc Corporate Summary
Table 86. DCC Plc Penicillamine Product Offerings
Table 87. DCC Plc Penicillamine Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2017-2022)
Table 88. Penicillamine Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 89. Global Penicillamine Capacity Market Share of Key Manufacturers, 2020-2022
Table 90. Global Penicillamine Production by Region, 2017-2022 (K Units)
Table 91. Global Penicillamine Production by Region, 2023-2028 (K Units)
Table 92. Penicillamine Market Opportunities & Trends in Global Market
Table 93. Penicillamine Market Drivers in Global Market
Table 94. Penicillamine Market Restraints in Global Market
Table 95. Penicillamine Raw Materials
Table 96. Penicillamine Raw Materials Suppliers in Global Market
Table 97. Typical Penicillamine Downstream
Table 98. Penicillamine Downstream Clients in Global Market
Table 99. Penicillamine Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. Penicillamine Segment by Type
Figure 2. Penicillamine Segment by Application
Figure 3. Global Penicillamine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Penicillamine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Penicillamine Revenue, 2017-2028 (US$, Mn)
Figure 7. Penicillamine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Penicillamine Revenue in 2021
Figure 9. By Type - Global Penicillamine Sales Market Share, 2017-2028
Figure 10. By Type - Global Penicillamine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Penicillamine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Penicillamine Sales Market Share, 2017-2028
Figure 13. By Application - Global Penicillamine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Penicillamine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Penicillamine Sales Market Share, 2017-2028
Figure 16. By Region - Global Penicillamine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Penicillamine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Penicillamine Sales Market Share, 2017-2028
Figure 19. US Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Penicillamine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Penicillamine Sales Market Share, 2017-2028
Figure 24. Germany Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 25. France Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Penicillamine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Penicillamine Sales Market Share, 2017-2028
Figure 33. China Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 37. India Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Penicillamine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Penicillamine Sales Market Share, 2017-2028
Figure 40. Brazil Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Penicillamine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Penicillamine Sales Market Share, 2017-2028
Figure 44. Turkey Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Penicillamine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Penicillamine by Region, 2021 VS 2028
Figure 50. Penicillamine Industry Value Chain
Figure 51. Marketing Channels
Figure 1. Penicillamine Segment by Type
Figure 2. Penicillamine Segment by Application
Figure 3. Global Penicillamine Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Penicillamine Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Penicillamine Revenue, 2017-2028 (US$, Mn)
Figure 7. Penicillamine Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Penicillamine Revenue in 2021
Figure 9. By Type - Global Penicillamine Sales Market Share, 2017-2028
Figure 10. By Type - Global Penicillamine Revenue Market Share, 2017-2028
Figure 11. By Type - Global Penicillamine Price (US$/Unit), 2017-2028
Figure 12. By Application - Global Penicillamine Sales Market Share, 2017-2028
Figure 13. By Application - Global Penicillamine Revenue Market Share, 2017-2028
Figure 14. By Application - Global Penicillamine Price (US$/Unit), 2017-2028
Figure 15. By Region - Global Penicillamine Sales Market Share, 2017-2028
Figure 16. By Region - Global Penicillamine Revenue Market Share, 2017-2028
Figure 17. By Country - North America Penicillamine Revenue Market Share, 2017-2028
Figure 18. By Country - North America Penicillamine Sales Market Share, 2017-2028
Figure 19. US Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 20. Canada Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe Penicillamine Revenue Market Share, 2017-2028
Figure 23. By Country - Europe Penicillamine Sales Market Share, 2017-2028
Figure 24. Germany Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 25. France Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 27. Italy Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 28. Russia Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia Penicillamine Revenue Market Share, 2017-2028
Figure 32. By Region - Asia Penicillamine Sales Market Share, 2017-2028
Figure 33. China Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 34. Japan Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 37. India Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America Penicillamine Revenue Market Share, 2017-2028
Figure 39. By Country - South America Penicillamine Sales Market Share, 2017-2028
Figure 40. Brazil Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa Penicillamine Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa Penicillamine Sales Market Share, 2017-2028
Figure 44. Turkey Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 45. Israel Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 47. UAE Penicillamine Revenue, (US$, Mn), 2017-2028
Figure 48. Global Penicillamine Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production Penicillamine by Region, 2021 VS 2028
Figure 50. Penicillamine Industry Value Chain
Figure 51. Marketing Channels
